Sign in

CIK 0001000694

  • Large accelerated filer

NOVAVAX INC

Sign in to watch
Ticker
NVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222816046
Phone
+1 240-268-2000
Business address
21 FIRSTFIELD RD, GAITHERSBURG, MD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-09-28 Herrmann John A III EVP, Chief Legal Officer Sale −719.55 $113.02 $81K 21,180
2020-09-28 Herrmann John A III EVP, Chief Legal Officer Sale −396.99 $113.81 $45K 20,783
2020-09-28 Herrmann John A III EVP, Chief Legal Officer Sale −992.48 $115.23 $114K 19,791
2020-09-28 Herrmann John A III EVP, Chief Legal Officer Sale −941.12 $116.08 $109K 18,850
2020-09-28 Herrmann John A III EVP, Chief Legal Officer Sale −545.86 $117.07 $64K 18,304
2020-09-28 Herrmann John A III EVP, Chief Legal Officer Exercise or conversion · Stock Option (Right to Buy) −24,750 74,250
2020-09-28 Glenn Gregory M President, R&D Exercise or conversion +25,000 $5.95 $149K 46,510
2020-09-28 Glenn Gregory M President, R&D Sale −275.69 $107.22 $30K 46,235
2020-09-28 Glenn Gregory M President, R&D Sale −3,739.1 $108.20 $405K 42,496
2020-09-28 Glenn Gregory M President, R&D Sale −6,661.4 $109.07 $727K 35,834
2020-09-28 Glenn Gregory M President, R&D Sale −8,132.83 $109.98 $894K 27,701
2020-09-28 Glenn Gregory M President, R&D Sale −2,343.11 $110.97 $260K 25,358
2020-09-28 Glenn Gregory M President, R&D Sale −215.54 $111.92 $24K 25,143
2020-09-28 Glenn Gregory M President, R&D Sale −726.82 $113.02 $82K 24,416
2020-09-28 Glenn Gregory M President, R&D Sale −401 $113.81 $46K 24,015
2020-09-28 Glenn Gregory M President, R&D Sale −1,002.51 $115.23 $116K 23,012
2020-09-28 Glenn Gregory M President, R&D Sale −950.63 $116.08 $110K 22,062
2020-09-28 Glenn Gregory M President, R&D Sale −551.38 $117.07 $65K 21,510
2020-09-28 Glenn Gregory M President, R&D Exercise or conversion · Stock Option (Right to Buy) −25,000 75,000
2020-09-28 Trizzino John EVP, CBO and CFO Exercise or conversion +25,000 $5.95 $149K 48,408

Page 78 of 87 · 1,734 trades